Accredited Investors’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-18,312
Closed -$1M 180
2022
Q2
$1M Sell
18,312
-33
-0.2% -$1.78K 0.12% 72
2022
Q1
$893K Hold
18,345
0.08% 83
2021
Q4
$766K Hold
18,345
0.07% 92
2021
Q3
$781K Buy
18,345
+50
+0.3% +$2.25K 0.08% 80
2021
Q2
$909K Hold
18,295
0.09% 77
2021
Q1
$989K Hold
18,295
0.13% 70
2020
Q4
$948K Hold
18,295
0.16% 65
2020
Q3
$797K Hold
18,295
0.17% 64
2020
Q2
$758K Hold
18,295
0.15% 64
2020
Q1
$601K Sell
18,295
-33
-0.2% -$1.58K 0.14% 68
2019
Q4
$1M Buy
18,328
+33
+0.2% +$1.7K 0.17% 55
2019
Q3
$880K Sell
18,295
-316
-2% -$15.1K 0.17% 57
2019
Q2
$920K Hold
18,611
0.18% 58
2019
Q1
$1.09M Buy
18,611
+33
+0.2% +$1.8K 0.22% 47
2018
Q4
$890K Buy
18,578
+5,461
+42% +$288K 0.2% 50
2018
Q3
$821K Buy
+13,117
New +$832K 0.2% 45

Other funds holding CDK

Accredited Investors's CDK Position: Q3 2022 in Review

Accredited Investors sold out of CDK Global, Inc. (CDK) in Q3 2022, closing a stake of 18,312 shares — an estimated $1M sold.

Accredited Investors first reported a position in CDK in Q3 2018 and held it in 16 quarters. The position peaked at $1.09M in Q1 2019. 6 funds tracked by Wall St. Rank hold CDK as of Q3 2022.

  • Accredited Investors reported no remaining CDK Global, Inc. position as of Q3 2022 after selling out during the quarter.
  • Accredited Investors sold 18,312 CDK Global, Inc. shares in Q3 2022, an estimated $1M.
  • Accredited Investors first reported a position in CDK Global, Inc. in Q3 2018 and held it in 16 quarters.
  • Accredited Investors's CDK Global, Inc. position peaked at $1.09M in Q1 2019.
  • 6 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q3 2022.

Based on Accredited Investors's 13F filing for Q3 2022, filed 8 Nov 2022.